Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL
Year: 2012
Type: article
Source: Nature Medicine
DOI: 10.1038/nm.2610
Institutions: Columbia University, Columbia University Irving Medical Center, Vlaams Instituut voor Biotechnologie, KU Leuven, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Montefiore Medical Center, New York Medical College, Technion – Israel Institute of Technology, Rambam Health Care Campus, Erasmus MC - Sophia Children’s Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W1984748997
